NYSE: OGNOrganon & Co Stock Ownership - Who owns Organon & Co?
Insider buying vs selling
Have Organon & Co insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Carrie Smith Cox | Director | 2025-05-14 | 12,469 | $8.07 | $100.59kBuy |
| Aaron Falcione | Chief Human Resources Officer | 2025-05-07 | 5,500 | $8.77 | $48.24kBuy |
| Kirke Weaver | Gen. Counsel Corp. Secy. | 2025-05-06 | 8,045 | $9.21 | $74.05kBuy |
| Daniel Karp | Executive VP Corp. Dev. | 2025-05-06 | 3,500 | $8.24 | $28.83kBuy |
| Kevin Ali | Chief Executive Officer | 2025-05-05 | 34,000 | $8.81 | $299.37kBuy |
| Matthew M. Walsh | Chief Financial Officer | 2025-05-05 | 11,400 | $8.82 | $100.55kBuy |
| Ferreira Juan Camilo Arjona | Head of RD CMO | 2025-03-31 | 3,172 | $14.51 | $46.03kSell |
| Rachel A. Stahler | Chief Information Officer | 2025-03-31 | 2,809 | $14.51 | $40.76kSell |
| Rachel A. Stahler | Chief Information Officer | 2025-03-31 | 2,645 | $14.51 | $38.38kSell |
| Rachel A. Stahler | Chief Information Officer | 2025-03-31 | 1,763 | $14.51 | $25.58kSell |
OGN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when OGN insiders and whales buy or sell their stock.
OGN Shareholders
What type of owners hold Organon & Co stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Blackrock Inc | 12.26% | 31,877,252 | $320.05M | Institution |
| Vanguard Group Inc | 11.43% | 29,701,733 | $298.21M | Institution |
| Massachusetts Financial Services Co | 4.12% | 10,715,445 | $107.58M | Institution |
| State Street Corp | 3.45% | 8,980,116 | $90.16M | Institution |
| Lsv Asset Management | 3.07% | 7,980,775 | $80.13M | Institution |
| Morgan Stanley | 2.16% | 5,612,574 | $56.35M | Institution |
| Sound Shore Management Inc | 1.91% | 4,977,078 | $49.97M | Institution |
| Nordea Investment Management Ab | 1.87% | 4,850,343 | $48.70M | Institution |
| Deprince Race Zollo Inc | 1.79% | 4,651,087 | $46.70M | Institution |
| Geode Capital Management LLC | 1.74% | 4,517,306 | $45.35M | Institution |
OGN vs General Drug Manufacturer Stocks
Organon & Co Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.